CEI
Clark Estates Inc Portfolio holdings
AUM
$446M
This Quarter Return
-2.76%
1 Year Return
+6.99%
3 Year Return
+36.03%
5 Year Return
+102.21%
10 Year Return
+152.93%
AUM
$634M
AUM Growth
+$634M
(-7.3%)
Cap. Flow
-$28.1M
Cap. Flow
% of AUM
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
38.17%
Holding
108
New
18
Increased
14
Reduced
16
Closed
18
Top Buys
| 1 |
Fiserv
FI
|
$22.8M |
| 2 |
Philips
PHG
|
$16M |
| 3 |
Cardinal Health
CAH
|
$10.6M |
| 4 |
Unilever
UL
|
$10.3M |
| 5 |
Comcast
CMCSA
|
$5.85M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$33.4M |
| 2 |
L3Harris
LHX
|
$12.8M |
| 3 |
Merck
MRK
|
$11.5M |
| 4 |
Pfizer
PFE
|
$10M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$7.18M |
Sector Composition
| 1 | Healthcare | 23.23% |
| 2 | Communication Services | 19.92% |
| 3 | Technology | 17.05% |
| 4 | Consumer Staples | 16.15% |
| 5 | Industrials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Verizon
VZ
$186B
| $31.1M | 4.9% | 609,593 +23,954 | +4% | +$1.22M |
|
2
Philip Morris
PM
$260B
| $29M | 4.58% | 308,800 | – | – |
|
|
3
Cardinal Health
CAH
$35.5B
| $28.9M | 4.56% | 509,600 +186,895 | +58% | +$10.6M |
|
|
4
Unilever
UL
$155B
| $23.9M | 3.78% | 525,000 +225,000 | +75% | +$10.3M |
|
5
3D Systems Corporation
DDD
$295M
| $23.7M | 3.73% | 1,418,614 | – | – |
|
|
6
Fiserv
FI
$75.1B
| $22.8M | 3.6% | +225,000 | New | +$22.8M |
|
7
Kraft Heinz
KHC
$33.1B
| $21.7M | 3.42% | 550,000 | – | – |
|
|
ATVI
8
DELISTED
Activision Blizzard Inc.
ATVI
| $21.3M | 3.35% | 265,300 -50,000 | -16% | -$4.01M |
|
9
Alphabet (Google) Class A
GOOGL
$2.57T
| $20.9M | 3.29% | 7,500 | – | – |
|
|
10
Comcast
CMCSA
$125B
| $18.7M | 2.96% | 400,000 +125,000 | +45% | +$5.85M |
|
|
11
Philips
PHG
$26.2B
| $16M | 2.53% | +525,000 | New | +$16M |
|
12
Interpublic Group of Companies
IPG
$9.83B
| $14.2M | 2.24% | 400,000 -15,315 | -4% | -$543K |
|
13
GSK
GSK
$79.9B
| $14.2M | 2.23% | 325,000 -125,000 | -28% | -$5.45M |
|
14
IBM
IBM
$227B
| $13.1M | 2.07% | 100,691 +8,000 | +9% | +$1.04M |
|
15
AbbVie
ABBV
$372B
| $13M | 2.06% | 80,400 -26,900 | -25% | -$4.36M |
|
16
Omnicom Group
OMC
$15.2B
| $11.8M | 1.87% | 139,400 | – | – |
|
|
EQC
17
DELISTED
Equity Commonwealth
EQC
| $11.3M | 1.78% | 400,000 -25,000 | -6% | -$705K |
|
|
18
Pfizer
PFE
$141B
| $10.2M | 1.6% | 196,390 -193,185 | -50% | -$10M |
|
19
International Flavors & Fragrances
IFF
$17.3B
| $9.85M | 1.55% | 75,000 +5,000 | +7% | +$657K |
|
20
FMC
FMC
$4.88B
| $9.21M | 1.45% | 70,000 -13,500 | -16% | -$1.78M |
|
21
Gilead Sciences
GILD
$140B
| $8.11M | 1.28% | 136,400 | – | – |
|
22
Corteva
CTVA
$50.4B
| $7.19M | 1.13% | 125,000 -25,000 | -17% | -$1.44M |
|
23
AT&T
T
$209B
| $7.09M | 1.12% | 300,000 +80,000 | +36% | +$1.89M |
|
24
General Dynamics
GD
$87.3B
| $6.03M | 0.95% | 25,000 -10,000 | -29% | -$2.41M |
|
25
Medtronic
MDT
$119B
| $5.55M | 0.88% | +50,000 | New | +$5.55M |
|